Sartorius with continued growth in a challenging environment
prnewswire.com
news
2022-10-19 05:00:00

Figures for the first nine months of 2022: Sales revenue up 16.6 percent in constant currencies, underlying EBITDA up 21.4 percent, underlying EBITDA margin at 33.8 percent
Both divisions with double-digit growth; as expected, swift normalization of demand in the Bioprocess Solutions division
Overall market situation characterized by innovations and strong growth drivers
Outlook for 2022 specified: Sales revenue growth now expected to be in the lower half of the previous range of 15 to 19 percent; projection for underlying EBITDA margin unchanged at about 34 percent
Uncertainties due to the global political and economic situation currently remain high

GÃ–TTINGEN, Germany, Oct.
